New NZ-Australian mRNA-based vaccine could be a gamechanger for malaria

A researcher at the Malaghan Institute, part of a trans-Tasman project working on a new malaria vaccine. (Image: The Malaghan Institute)

Greg Hurrell

Mon, 24 Jul 2023

Two Wellington research institutes have developed an mRNA-based malaria vaccine as part of a trans-Tasman research effort they describe as a breakthrough.Although there have been several announcements on malaria vaccines in recent years, the researchers say none have yet proved effective and long-lasting, citing the World Health Organisation (WHO).The Malaghan Institute of Medical Research and Victoria University of Wellington’s Ferrier Research Institute have been working through pre-clinical trials for a malaria vaccine with Melbourne&r...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Stay informed on business, government and financial developments across New Zealand.
Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

World

Afghan wedding halls light up sombre Kabul nights

Celebrating a marriage is a cultural must, even if it means going deeply into debt.

Agence France-Presse 5:00am

Books Interview

Author's South African experience shapes new novel

Lauren Francis-Sharma knows people may find 'Casualties of Truth' hard to read.

The Washington Post 5:00am

Author's South African experience shapes new novel

Technology Free Business of Tech podcast

Startups, being wrong, and near-death experiences

'The smart way is to try and build these companies up one at a time.'

Peter Griffin 5:00am

Startups, being wrong, and near-death experiences

Sponsored

Investing in US technology: Navigating a high-speed sector

A new exchange-traded fund gives Kiwis access to US tech giants.

Smart Invest

Sponsored

Security of supply: Marsden Point isn’t the issue as assurance offered for liquid fuel supply

How NZ will stay fuelled despite major global supply risks.

Z Energy

More Health

Health

Compass calls Pita Pit, pie shop to the rescue

Nutritionists are not impressed.

Cécile Meier 13 Feb 2025

Law & Regulation

Class action targets ‘ineffective’ cold medicines

A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not work.Australia-based JGA Saddler filed a class action against Johnson & Johnson NZ on Thursday over its phenylephrine-based cold medicines tablets and syrups...

Staff reporters 13 Feb 2025